Spectral AI Q4 Earnings Call Highlights

Spectral AI (NASDAQ: MDAI) executives said fiscal 2025 marked a "pivotal year" as the company advanced its DeepView burn diagnostic system toward potential FDA clearance and strengthened its funding profile, highlighted by a new award under its longstanding BARDA partnership. DeepView FDA path and clinical data Chief Executive Officer Vincent Capone said the company's June 2025